Jaguar Health (JAGX) Gross Profit (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Gross Profit of $19.1 million for Q1 2026, up 1025.01% year-over-year from $1.7 million in Q1 2025, and up 1746.76% quarter-over-quarter from $1.0 million in Q4 2025.
Jaguar Health (JAGX) Gross Profit (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Gross Profit for 12 consecutive years, with $19.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit rose 1025.01% year-over-year to $19.1 million; the TTM figure through Mar 2026 stood at $25.2 million (up 164.42% YoY), while the FY2025 annual figure was $7.7 million, down 20.52% from the prior year.
- Gross Profit advanced to $19.1 million in Q1 2026 per JAGX's latest filing, from $1.0 million in the prior quarter.
- Across five years, Gross Profit topped out at $19.1 million in Q1 2026 and bottomed at -$463000.0 in Q4 2022.
- Historically, Gross Profit has averaged $2.7 million across 5 years, with a median of $2.3 million in 2024.
- On a YoY basis, Gross Profit climbed as much as 126100.0% in 2022 and fell as far as 169.6% in 2022.
- Jaguar Health's Gross Profit stood at -$463000.0 in 2022, then jumped by 448.38% to $1.6 million in 2023, then jumped by 83.01% to $3.0 million in 2024, then slumped by 64.94% to $1.0 million in 2025, then surged by 1746.76% to $19.1 million in 2026.
- Business Quant data shows JAGX's Gross Profit at $19.1 million in Q1 2026, $1.0 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.11 Mn |
| Mar 31, 2026 | 19.11 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 2.95 Mn |
| Dec 31, 2024 | 2.95 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Dec 31, 2023 | 1.61 Mn |